WHO ICTRP trial
A clinic study to assess the clinical efficacy and immunological effects of…
ChiCTR-OCH-11001856 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OCH-11001856 |
|---|---|
| Public title | A clinic study to assess the clinical efficacy and immunological effects of gefitinib and standard chemotherapy in malignant pleural effusion caused by advanced non-small cell lung cancer |
| Scientific title | A single centre clinical study to assess the clinical efficacy and immunological effects of gefitinib and standard chemotherapy in malignant pleural effusion caused by advanced non-small cell lung cancer |
| Primary sponsor | Department of Respiratory Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | malignant pleural effusion caused by advanced non-small cell lung cancer |
| Interventions | 1:administer gefitinib orally;2:administer carboplatin/paclitaxel intravenously |
| Registration date | Dec 31, 2011 |
| Target size | 1:30;2:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: